[Treatment of rheumatoid arthritis with adalimumab. Results from a Cochrane review].
Pedersen
Susanne Juhl
SJ
Amtssygehuset i Herlev, Medicinsk Reumatologisk Geriatrisk Afdeling, og H:S Hvidovre Hospital.
Hetland
Merete Lund
ML
Østergaard
Mikkel
M
D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000068879:Adalimumab; D008727:Methotrexate